MRI quantitative imaging biomarkers in differentiating brain parenchymal tuberculoma and lung cancer brain metastases.
MRI radiomics model distinguishes brain tuberculoma from lung cancer metastases with AUC up to 0.986. 📊🧠
December 17, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 🧬 Rare Diseases.
Quantitative Imaging for Interstitial Lung Disease.
Quantitative imaging enhances ILD diagnosis and treatment, utilizing CT and emerging MRI techniques. 📊🫁
December 5, 2025
Artificial Intelligence and Radiogenomics for Pediatric CNS Neoplasms.
AI & Radiogenomics in Pediatric CNS Tumors: 2021 WHO guidelines enhance diagnosis via molecular profiling. Promising future ahead! 🧠✨
November 23, 2025
Rare disease education in medical schools: patient-centered and innovative strategies.
Rare diseases affect 300 million globally. Medical education must adapt to improve care. 📚💉
November 22, 2025
Cracking the code: a head-to-head comparison of expert clinicians and artificial intelligence in diagnosing rare diseases.
AI vs. Clinicians: 28% Diagnosis Match in Rare Diseases 🤖🩺
November 7, 2025
New avenues in childhood vasculitis.
Exploring childhood vasculitis: recent advances in diagnosis, treatment, and future directions. 📊🩺
October 8, 2025
New Wearable Device Aims to Monitor Muscle Health in Older Adults
New wearable device monitors muscle health in older adults. 🦵📈 Aims to detect sarcopenia for timely intervention.
September 29, 2025
Lung lobe segmentation: performance of open-source MOOSE, TotalSegmentator, and LungMask models compared to a local in-house model.
Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. 📊🫁
September 5, 2025
Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025).
📈 Retinoblastoma biomarkers research shows steady growth, with China leading publications. Key hotspots include liquid biopsy and AI integration. 🔬
August 16, 2025
Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.
Bimodal imaging probes enhance disease diagnosis and therapy, combining MRI and fluorescence for improved precision. 🧬🔬
August 4, 2025